Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: lumacaftor + ivacaftor
What it is used for
ORKAMBI is indicated for the treatment of cystic fibrosis (CF) in patients age 12 years and older who are homozygous for the F508del mutation in the CFTR gene.
How to take it
- The way to take this medicine: Oral
- Store below 30 degrees Celsius
- Store in Original Container
- Shelf lifetime is 24 Months.
Always read the label. If symptoms persist see your healthcare professional.
Orkambi is a pink, oval-shaped, film-coated tablet, printed in black ink with 2V125 on one face.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2018. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient lumacaftor + ivacaftor
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems